EUVIMEDSkopri EUVIMED
Open access · CC BY-NC 4.0

Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome

Magdy El-Salhy iD, Odd Helge Gilja iD, Jan Gunnar Hatlebakk iD

Neurogastroenterology & Motility · 2024

DOI: 10.1111/nmo.14641 ↗

At a glance

Journal article in Neurogastroenterology & Motility, 2024. Written by Magdy El-Salhy and 2 co-authors. Institution: Department of Research and Innovation, Helse Fonna, Stord, Norway. Major MEDLINE topics: Irritable Bowel Syndrome, Gastrointestinal Microbiome. Cited 17 times so far (Crossref); 27 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Hesle Fonna.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

A previous study that introduced a Fecal microbiota transplantation (FMT) protocol with a high efficacy applied a combination of favorable factors.

Aims

The present study aimed to evaluate some of these factors.

Methods

This study included 186 patients with IBS randomized 1:1:1 into transplant administered to the colon (single LI), to the duodenum (single SI), or to the duodenum twice with a 1‐week interval (repeated SI). The patients provided a fecal sample and were asked to complete five questionnaires at baseline and at 3, 6, and 12 months after FMT. The fecal bacteria composition and dysbiosis index (DI) were analyzed using 16S rRNA gene PCR DNA amplification/probe hybridization covering regions V3–V9.

Results

The response rate was significantly higher in single SI than in single LI at 12 months after FMT. Symptoms and quality of life improved in all the treated groups at all time intervals after FMT. The abdominal symptoms were significantly reduced and the quality of life improved for repeated SI compared with for single SI. DI significantly decreased in all the treated groups at all observation times after FMT. The bacterial profiles changed in all groups at all observation intervals. However, these changes differed between single LI and single SI/repeated SI.

Conclusion

Administrating transplant to the small intestine had a long‐term higher response rate than that administrated to the large intestine, and led to long‐term colonization of beneficial bacteria. Repeating FMT had more effect on symptoms and quality of life than a single FMT. ( www.clinicaltrials.gov : NCT04236843).

Subjects

MeSH terms (MEDLINE)

Irritable Bowel SyndromeGastrointestinal MicrobiomeHumansFecal Microbiota TransplantationQuality of LifeRNA, Ribosomal, 16STreatment OutcomeFecesDysbiosisBacteria

Author keywords

Holdemanella biformisLactobacillus spp.dysbiosisfatigue

Substances

RNA, Ribosomal, 16S

Authors and institutions

  • Department of Research and Innovation, Helse Fonna, Stord, Norway.
  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • National Centre for Functional Gastrointestinal Disorders, Department of Medicine, Haukeland University Hospital, Bergen, Norway.

ORCID profiles: Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk

Funding

  • Hesle Fonna

Cite

APA

El-Salhy, M., Gilja, O. H., & Hatlebakk, J. G. (2024). Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14641

Vancouver

El-Salhy M, Gilja OH, Hatlebakk JG. Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome. Neurogastroenterology & Motility. 2024. doi:10.1111/nmo.14641

BibTeX
@article{ElSalhy2024,
  author = {El-Salhy, Magdy and Gilja, Odd Helge and Hatlebakk, Jan Gunnar},
  title = {Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome},
  journal = {Neurogastroenterology & Motility},
  year = {2024},
  doi = {10.1111/nmo.14641}
}
Start for free →